Generics 8

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Sulfamethoxazole manufacturers

8 products found

Filters

Filters

Filters , active

Country of origin : Malaysia

Clear all

8 products found

sulfamethoxazole + trimethoprim

Oral suspension 200 mg + 40 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Malaysia
GMP approvals
Malaysia
Manufacturer #20939
It was incorporated in the 1980s as a small-scale manufacturer of generic pharmaceuticals. Following the implementation of GMP requirements by the Ministry of Health and the expansion of the business operations. They also provide OEM facilities with the same stringent standards of quality and acceptability that apply to their home-brand products.

Manufacturer usually replies in 8 days

sulfamethoxazole + trimethoprim

Tablets 400 mg + 80 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Malaysia
GMP approvals
Malaysia
Manufacturer #20939
It was incorporated in the 1980s as a small-scale manufacturer of generic pharmaceuticals. Following the implementation of GMP requirements by the Ministry of Health and the expansion of the business operations. They also provide OEM facilities with the same stringent standards of quality and acceptability that apply to their home-brand products.

Manufacturer usually replies in 8 days

sulfamethoxazole

Oral suspension 200mg/5ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Malaysia
GMP approvals
Malaysia
Manufacturer #1447
The company was established in the early 1990s. It is one of the largest integrated pharmaceutical groups with a firm focus on protecting the nation via providing accessible and affordable healthcare solutions, with operations in Malaysia and Indonesia. It is involved in various segments of the pharmaceutical value chain, including research and development, manufacturing of generic drugs and medical devices, logistics and distribution, sales and marketing, as well as a community pharmacy.

Manufacturer usually replies in 6 days

sulfamethoxazole + trimethoprim

Tablets tbd

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Malaysia
Manufacturer #1447
The company was established in the early 1990s. It is one of the largest integrated pharmaceutical groups with a firm focus on protecting the nation via providing accessible and affordable healthcare solutions, with operations in Malaysia and Indonesia. It is involved in various segments of the pharmaceutical value chain, including research and development, manufacturing of generic drugs and medical devices, logistics and distribution, sales and marketing, as well as a community pharmacy.

Manufacturer usually replies in 6 days

trimethoprim + sulfamethoxazole

Granules for oral suspension 40 mg + 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Malaysia
GMP approvals
EU GMP
Manufacturer #20853
The company’s mission is to invest in and operate businesses that restore health and enhances the lives of those they serve. Healthcare professionals use medicines and diagnostic devices to treat and manage infections, cardiovascular, metabolic, gastroenterological, rheumatic conditions, and more.

Manufacturer usually replies in 4 days

trimethoprim + sulfamethoxazole

Tablets 80 mg + 400 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Malaysia
GMP approvals
EU GMP
Manufacturer #20853
The company’s mission is to invest in and operate businesses that restore health and enhances the lives of those they serve. Healthcare professionals use medicines and diagnostic devices to treat and manage infections, cardiovascular, metabolic, gastroenterological, rheumatic conditions, and more.

Manufacturer usually replies in 4 days

trimethoprim + sulfamethoxazole

Oral suspension 1:5; 240mg/5ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Malaysia
GMP approvals
WHO, PICS
Manufacturer #540

Manufacturer usually replies in 18 days

trimethoprim + sulfamethoxazole

Tablets 1:5; 480mg, 960mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Malaysia
GMP approvals
WHO, PICS
Manufacturer #540

Manufacturer usually replies in 18 days

What is SULFAMETHOXAZOLE?

Sulfamethoxazole is also known as (SMZ or SMX). This is a generic pharmaceutical substance. It is an antibiotic. This pharmaceutical drug is practiced for bacterial germs such as urinary field diseases, bronchitis, and prostatitis and is useful upon both gram-negative and confident bacteria before-mentioned as Listeria monocytogenes and E. coli. This remedy is a mixture of two antimicrobials: sulfamethoxazole and trimethoprim. It is applied to employ an extensive assortment of bacterial contaminations (such as middle hearing, urine, respiratory, and abdominal diseases). It is additionally used to stop and employ a specific type of pneumonitis(pneumocystis-type).

How Does SULFAMETHOXAZOLE Work?

This pharmaceutical medicine is an anti-bacterial sulfonamide, a "sulfa" medication. It upsets the reproduction of dihydrofolic psychedelic while trimethoprim intrudes the reproduction of tetrahydrofolic acid. Dihydrofolic acid and tetrahydrofolic acid are forms of folic acid that bacteria and individual cells employ for constructing proteids.

The Wholesale Price of SULFAMETHOXAZOLE

The price for sulfamethoxazole/trimethoprim articulated dose (800 mg-160 mg) is proximate $10 for an accumulation of 2 tablets, depending on the pharmacy you visit. Prices are for cash-paying consumers simply plus are not valid with protection policies.

SULFAMETHOXAZOLE Manufactures and Sippliers

PipelinePharma has found 98 verified sulfamethoxazole manufacturers and sulfamethoxazole suppliers from our global list of sellers. The pharmaceutical drug is available for sale in different forms such as syrup, tablets, oral suspension, capsules from manufacturers in various countries including Serbia, European Union, Ukraine, Macedonia, Albania, Israel, Kosovo.

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of sulfamethoxazole offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for sulfamethoxazole manufacturers and sulfamethoxazole suppliers that you are looking for. These also enable you to check the dossier status of sulfamethoxazole, and the GMP approvals of the different variants of sulfamethoxazole. Also, each manufacturer or supplier product description contains essential information about sulfamethoxazole including clinical data, stability zones, countries where sulfamethoxazole is already registered in. Manufacturers also specify the commercial terms of their offers, such as the market for which the offer is intended, deal type, dossier licensing fee, supply price, payment terms, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over sulfamethoxazole offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that sulfamethoxazole manufacturers have, we qualify their companies before they are on-boarded on the platform. This allows us to screen sulfamethoxazole manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.